 Record date : **PHI** Oncology COMPLETION NOTE Patient : **PHI** **PHI** # **PHI** RADIATION ONCOLOGIST : **PHI** M. **PHI** , MD DATES OF RADIATION : **PHI** - **PHI** ( **PHI** **PHI** days ) DIAGNOSIS : Prostate adenocarcinoma T2B Nx , Gleason **PHI** = **PHI** , PSA **PHI** CONCISE HISTORY : Mr. **PHI** is a **PHI** year old man who was found to have an elevated PSA of **PHI** on screening exam . An abnormality was also noted on DRE at that time . Prostate biopsy was performed , and all **PHI** cores were positive for disease , including **PHI** cores with Gleason **PHI** disease . Prostatic MRI showed no evidence of extracapsular extension . CT of the abdomen and bone scan revealed no evidence of metastatic disease . He was treated with definitive radiation to the prostate and seminal vesicles by **PHI** , with concomitant Zoladex treatment . SPECIAL TECHNICAL **PHI** : The patient underwent **PHI** imaging to define the target volume and the normal tissue structures and 3D treatment planning was performed for treatment with **PHI** . Daily localization of the prostate was done using the BAT ultrasound . SUMMARY OF RADIATION AND TREATMENT ADMINISTERED : The treatment site was the prostate gland plus the caudal seminal vesicles followed by a boost to the prostate alone . The patient underwent external beam radiotherapy to the prostate and caudal seminal vesicles to a dose of **PHI** Gy given as **PHI** fractions of **PHI** **PHI** . He then underwent a boost to the prostate only of **PHI** . Gy given in **PHI** fractions of **PHI** **PHI** for a total dose of **PHI** Gy . CLINICAL COURSE : The patient developed mild nocturia and more frequent bowel movements , for which he took Flomax and Metamucil . Mr. **PHI** has tolerated his androgen deprivation therapy well . FOLLOW-UP : Mr. **PHI** will follow up with us in **PHI** months with a PSA in advance . Ulysses **PHI** , MD ( Resident ) **PHI** **PHI** , MD ( Attending ) cc :